BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6859017)

  • 1. Steatohepatitis in obese children: a cause of chronic liver dysfunction.
    Moran JR; Ghishan FK; Halter SA; Greene HL
    Am J Gastroenterol; 1983 Jun; 78(6):374-7. PubMed ID: 6859017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obese children with steatohepatitis can develop cirrhosis in childhood.
    Molleston JP; White F; Teckman J; Fitzgerald JF
    Am J Gastroenterol; 2002 Sep; 97(9):2460-2. PubMed ID: 12358273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The liver of the severely obese patient treated with a jejuno-ileal shunt. Functional and morphological aspects].
    Scopinaro N; Badini A; Gianetta E; Bonalumi U
    Minerva Chir; 1976 May; 31(10):577-86. PubMed ID: 972734
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nonalcoholic steatohepatitis. Three case reports].
    Eivindson MV; Hamilton-Dutoit S; Grønbaek H
    Ugeskr Laeger; 2003 Mar; 165(11):1118-20. PubMed ID: 12677986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity: a cause of steatohepatitis in children.
    Koçak N; Yüce A; Gürakan F; Ozen H
    Am J Gastroenterol; 2000 Apr; 95(4):1099-100. PubMed ID: 10763980
    [No Abstract]   [Full Text] [Related]  

  • 7. The natural history of nonalcoholic fatty liver: a follow-up study.
    Teli MR; James OF; Burt AD; Bennett MK; Day CP
    Hepatology; 1995 Dec; 22(6):1714-9. PubMed ID: 7489979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-alcoholic steato-hepatitis].
    Linhart HG
    Praxis (Bern 1994); 2000 May; 89(22):963-6. PubMed ID: 10893995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months.
    Keshishian A; Zahriya K; Willes EB
    Obes Surg; 2005; 15(10):1418-23. PubMed ID: 16354521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nonalcoholic steatohepatitis in children].
    Cubelić S; Misak Z; Gasparov S; Kolacek S
    Lijec Vjesn; 2004; 126(7-8):197-200. PubMed ID: 15754789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
    Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
    Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive histological damage in liver allografts following pediatric liver transplantation.
    Evans HM; Kelly DA; McKiernan PJ; Hübscher S
    Hepatology; 2006 May; 43(5):1109-17. PubMed ID: 16628633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orlistat in the treatment of NASH: a case series.
    Harrison SA; Ramrakhiani S; Brunt EM; Anbari MA; Cortese C; Bacon BR
    Am J Gastroenterol; 2003 Apr; 98(4):926-30. PubMed ID: 12738478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.
    Abraham SC; Poterucha JJ; Rosen CB; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2008 Jul; 32(7):965-73. PubMed ID: 18460980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver pathology in obesity.
    Suriawinata A; Fiel MI
    Semin Liver Dis; 2004 Nov; 24(4):363-70. PubMed ID: 15605304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic steatohepatitis in children.
    Roberts EA
    Clin Liver Dis; 2007 Feb; 11(1):155-72, x. PubMed ID: 17544977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver damage in obese patients.
    Del Gaudio A; Boschi L; Del Gaudio GA; Mastrangelo L; Munari D
    Obes Surg; 2002 Dec; 12(6):802-4. PubMed ID: 12568185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
    Jansen PL
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.
    Haukeland JW; Konopski Z; Linnestad P; Azimy S; Marit Løberg E; Haaland T; Birkeland K; Bjøro K
    Scand J Gastroenterol; 2005 Dec; 40(12):1469-77. PubMed ID: 16293559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.